Table 2.
Frequency of epidemiopathogenic (EP) forms (apparently free-AF, latent-LAT and patent-PAT) according to progression risk level.
| AF |
LAT |
AF + LAT |
PAT |
||||
|---|---|---|---|---|---|---|---|
| N | % | N | % | N/% | N | % | |
| LOWIN | 37 | 94.9 | 2 | 5.1 | 39/100% | 0 | 0.0 |
| LATIN | 1 | 5.9 | 16 | 94.1 | 17/100% | 0 | 0.0 |
| PATIN | 10 | 33.3 | 8 | 26.7 | 18/60% | 12 | 40.0 |
| AVERIN |
217 |
52.2 |
159 |
38.2 |
376/90.4% |
40 |
9.6 |
| Total | 265 | 52.8 | 185 | 36.9 | 450/89.6% | 52 | 10.4 |
LOWIN: Apparently free EP form risk or low infection progression risk. LATIN: Latent EP form risk or latent infection progression risk. PATIN: Patent EP form risk or infection progression high risk. AVERIN: SNP combinations that did not fit into any of the above mentioned groups. Bold values indicates percentages.